RNA
Atrium Therapeutics, Inc.Company with tickers: RNA
CIK
2093101
CUSIP
04965N104
Shares Outstanding
17,105,643
13F Activity (30d)
122 filings
122 filers
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 129,546 | 463,782 | 593,328 | 59.7% |
| 2026-04-27 | 227,742 | 416,621 | 644,363 | 54.4% |
| 2026-04-20 | 483,645 | 756,666 | 1,240,311 | 54.1% |
| 2026-04-13 | 698,775 | 1,722,241 | 2,421,016 | 100.0% |
| 2026-04-06 | 541,050 | 114,124 | 655,174 | 35.1% |
| 2026-03-30 | 384,775 | 627,493 | 1,012,268 | 55.6% |
| 2026-03-23 | 489,053 | 860,616 | 1,349,669 | 52.9% |
| 2026-03-16 | 659,748 | 1,566,492 | 2,226,240 | 55.6% |
| 2026-03-09 | 892,880 | 363,208 | 1,256,088 | 36.1% |
| 2026-03-02 | 2,847,545 | 1,045,759 | 3,893,304 | 35.9% |
| 2026-02-23 | 9,460,954 | 13,968,906 | 23,429,860 | 100.0% |
| 2026-02-16 | 1,658,078 | 8,175,814 | 9,833,892 | — |
| 2026-02-09 | 1,698,778 | 4,645,470 | 6,344,248 | — |
| 2026-02-02 | 1,996,956 | 6,663,685 | 8,660,641 | — |
| 2026-01-26 | 668,580 | 2,126,953 | 2,795,533 | — |
| 2026-01-19 | 922,084 | 1,803,989 | 2,726,073 | — |
| 2026-01-12 | 1,474,213 | 1,124,205 | 2,598,418 | — |
| 2026-01-05 | 1,598,122 | 4,901,758 | 6,499,880 | — |
| 2025-12-29 | 1,134,537 | 1,225,644 | 2,360,181 | — |
| 2025-12-22 | 1,024,658 | 980,003 | 2,004,661 | — |
| 2025-12-15 | 2,993,402 | 2,752,520 | 5,745,922 | — |
Showing 1–21 of 21 weeks